Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2500 of 2873 entries
View as:

Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02106988 Org: User:
Start: 01/16/15 End: 01/31/34 Due: 01/31/35

PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification

Phase: N/A Priority: Normal
NCT ID: NCT05049837 Org: User:
Start: 04/25/07 End: 12/31/25 Due: 12/31/26

A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06065449 Org: User:
Start: 01/24/24 End: 06/27/27 Due: 06/27/28

Alemtuzumab + Rituximab Consolidation in CLL

Phase: N/A Priority: Normal
NCT ID: NCT00771602 Org: User:
Start: 08/31/08 End: 12/31/10 Due: 12/31/11

Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use

Phase: N/A Priority: Normal
NCT ID: NCT00799669 Org: User:
Start: 12/05/07 End: 02/29/20 Due: 02/28/21

A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene Field Treatments in Patients With Multiple Actinic Keratoses

Phase: N/A Priority: Normal
NCT ID: NCT06851507 Org: User:
Start: 05/01/25 End: 08/31/27 Due: 08/31/28

Trial of Primary Prophylaxis With rhTPO Administered to Patients With High Risk Sarcoma Receiving Intensive Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00283582 Org: User:
Start: 06/30/01 End: 11/30/04 Due: 11/30/05

Pembrolizumab in Treating Patients With Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT02337686 Org: User:
Start: 04/28/15 End: 12/31/26 Due: 12/31/27

Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03383575 Org: User:
Start: 01/17/18 End: 02/28/27 Due: 02/28/28

Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04678414 Org: User:
Start: 04/01/19 End: 02/02/27 Due: 02/02/28

A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study)

Phase: N/A Priority: Normal
NCT ID: NCT05035732 Org: User:
Start: 03/25/21 End: 01/17/24 Due: 01/17/25

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04219904 Org: User:
Start: 09/07/18 End: 09/30/25 Due: 09/30/26

Fentanyl for Breakthrough Pain in the Emergency Department

Phase: N/A Priority: Normal
NCT ID: NCT01812759 Org: User:
Start: 01/10/14 End: 10/22/14 Due: 10/22/15

Edmonton Symptom Assessment Scale: Self-Completion vs. Assisted-Completion

Phase: N/A Priority: Normal
NCT ID: NCT02523378 Org: User:
Start: 08/13/15 End: 12/03/20 Due: 12/03/21

Pilot Study to Develop 3 Tesla MRI for Evaluation of Renal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00507884 Org: User:
Start: 03/31/05 End: 09/01/22 Due: 09/01/23

Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix

Phase: N/A Priority: Normal
NCT ID: NCT05046080 Org: User:
Start: 08/06/21 End: 09/29/26 Due: 09/29/27

A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06434402 Org: User:
Start: 05/22/24 End: 09/01/26 Due: 09/01/27

Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT03174197 Org: User:
Start: 06/30/17 End: 12/12/25 Due: 12/12/26

Lenalidomide and Obinutuzumab in Treating Patients With Relapsed Indolent Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01995669 Org: User:
Start: 05/27/14 End: 01/23/23 Due: 01/23/24

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics

Phase: N/A Priority: Normal
NCT ID: NCT05694559 Org: User:
Start: 11/23/22 End: 02/02/27 Due: 02/02/28

Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients

Phase: N/A Priority: Normal
NCT ID: NCT01031602 Org: User:
Start: 10/31/07 End: 05/31/13 Due: 05/31/14

A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias

Phase: N/A Priority: Normal
NCT ID: NCT06397027 Org: User:
Start: 12/27/24 End: 12/31/30 Due: 12/31/31

Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03799445 Org: User:
Start: 07/25/19 End: 06/30/26 Due: 06/30/27

Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy

Phase: N/A Priority: Normal
NCT ID: NCT05431595 Org: User:
Start: 07/19/22 End: 02/02/27 Due: 02/02/28

Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking

Phase: N/A Priority: Normal
NCT ID: NCT03668769 Org: User:
Start: 03/27/17 End: 03/04/20 Due: 03/04/21